Company Active ROYAL-CHARTER

Company profile

King's College London

King's College London

King's College London is a UK company with status active founded in 1981.

CRN
RC000297
Founded
1981
Age
45

Overview

Legal name
KING'S COLLEGE LONDON
Region
Unknown
Registered address
Unknown
Insolvency history
No

Corporate ownership

Updated 06 Jun 2026 16:52

King's College London
No active corporate controller recorded.

Company events

Reference milestones and recent Companies House filing stream events.

2 events
15 Jan
2017

Confirmation statement due

Confirmation Due

Next confirmation statement due date

01 Jan
1981

Incorporated

Inception

Company registered at Companies House

Public funding

123 awards
First funded
2005
Funded years
2005, 2006, 2007, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018, 2019, 2020, 2021, 2022, 2023, 2024, 2025
Age at first award
24 years

Projects

2025 Collaborative R&D

V-Health: Gamified immersive functional electrical stimulation system for efficient upper limb neurorehabilitation

1 May 2025 to 30 Apr 2026

Awarded
£42,536
Total cost £42,536

This project is focused on developing a new technology for upper limb neurorehabilitation combining functional electrical stimulation (FES) and extended reality (XR) - **v-health**. We propose that XR will improve engagement and motivation through immersive gamification, in addition to improved task performance through the use of FES. Together, they will ...

2024 Knowledge Transfer Partnership Lead participant

King's College London and ControlPlane Limited KTP 23_24 Round 5

1 Dec 2024 to 30 Nov 2026

Awarded
£121,578
Total cost £181,460

To develop an automated tool for the security of the Kubernetes platform, on which critical cloud infrastructure relies. The tool will be built on formal principles using rigorous mathematical techniques. It will empower companies to secure their critical infrastructure by minimising the risk of cyber threats in a cost-efficient manner.

2024 CR&D Bilateral

Parallelised ultra high-density electrophysiological assays to power epilepsy precision medicine

1 Dec 2024 to 30 Nov 2026

Awarded
£88,468
Total cost £88,468

Epilepsy is a brain condition characterized by the occurrence of seizures, significantly impacting the lives of those affected. This is especially the case when it is caused by genetic factors and manifests early in life. Despite current treatments, finding effective seizure control remains a challenge, underscoring the urgent need for innovative therapie...

2024 Grant for R&D

Smart Grid Safe Data Transmission via Power Converter and Power Signal Multiplex Modulation ("Grid-Enigma")

1 Oct 2024 to 30 Sep 2025

Awarded
£119,582
Total cost £119,582

In seeking to achieve decarbonisation, we face a challenge: while we're switching to renewable sources like solar and wind, there's a risk that this leads to higher electricity prices, hitting those who can't afford it the hardest. To make renewable energy work smoothly, we need special converters that turn sunlight and wind into usable electricity and ma...

2024 EU-Funded Lead participant

AUTOMated enriched digitisation of Archaeological liThics and cerAmics

1 Sep 2024 to 28 Feb 2029

Awarded
£359,211
Total cost £359,211

Objects connect us to memories and experiences. They possess biographies that reveal their human relationships. This is why archaeologists focus on material culture, gathering countless archaeological finds to preserve what we can learn and the stories they create for current and future generations. Archaeology unlocks these stories, enabling objects to s...

2024 Collaborative R&D

Self-learning AI Copilots to Enable Personalised Medicine Manufacturing

1 Sep 2024 to 31 Aug 2026

Awarded
£234,726
Total cost £234,726

This project seeks to develop a data-efficient vision-based AI process monitoring system to seamlessly assure additive manufacturing (AM) part quality in real-time, thereby accelerating AM adoption including in our case study of personalised pharmaceuticals. Our key innovation will address a fundamental challenge with AI systems: they typically need a lot...

2024 Collaborative R&D

LockEyeGaze: Gaze-Enhanced Authentication Technology

1 Sep 2024 to 28 Feb 2025

Awarded
£5,654
Total cost £5,654

Our project addresses the growing cybersecurity challenges posed by advanced computer vision and 3D modeling technologies, which have begun to compromise the reliability of facial recognition as a secure authentication method. In response, we are developing an innovative authentication system based on eye movement patterns. This non-invasive biometric app...

2024 Collaborative R&D

PRESERVE-CR: a robotic assistant to standardise oocyte and embryo vitrification and improve the cost-effectiveness of IVF treatment

1 Jul 2024 to 30 Jun 2026

Awarded
£378,585
Total cost £378,585

In vitro fertilisation (IVF) is an effective fertility treatment which however remains out of reach for 60% of UK patients due to high costs, arising from the need for highly trained staff and bespoke laboratories. The NHS only funds limited IVF cycles, while private clinics are operating at near-full capacity. Radical, scalable solutions to cut IVF costs...

2024 EU-Funded Lead participant

PROTID_Randomised Controlled Trial of Preventive Treatment of Latent Tuberculosis Infection in Patients with Diabetes Mellitus

1 Jul 2024 to 31 Dec 2026

Awarded
£69,704
Total cost £69,704

Diabetes Mellitus(DM) contributesto an estimated 11.3% of adult deaths worldwide. Approximately 1 in 10 adults globally are estimated to have DM and the prevalence will rise significantly over the coming decades, especially in sub-Saharan Africa. People with DM have a three-fold increased risk of developing TB, and two-fold higher risk of dying from TB or...

2024 EU-Funded Lead participant

RESPOND: Rescuing Democracy from Political Corruption in Digital Societies

1 May 2024 to 30 Apr 2029

Awarded
£395,755
Total cost £395,755

Corruption and undue influences are not only linked to democratic discontent but compromise the quality of democracy. But how exactly does political corruption operate today? How deep can its negative impact on democracy go? And how can anti-corruption efforts recover people’s support for democracy as a regime and promote their engagement with integrity a...

2024 Knowledge Transfer Partnership Lead participant

King’s College London and Global Shea Alliance AAKTP 23_24 R3

1 May 2024 to 30 Apr 2026

Awarded
£177,001
Total cost £177,001

To develop an innovative carbon and biodiversity credit accreditation, monitoring and management platform that will enable smallholder farmers in Ghana finance the uptake and maintenance of a sustainable shea farming model that will improve primary crop production, availability and accessibility of healthy and nutritious food and contribute to farmers' in...

2024 Collaborative R&D Lead participant

Assessing the Feasibility of a Neurosymbolic Methodology for Bias Mitigation of Cardiac Arrest Early Warning in General Wards

1 May 2024 to 31 Mar 2025

Awarded
£129,939
Total cost £129,939

Clinical early warning scores (EWS) are widely used by hospital care teams to identify early signs of patient deterioration, to facilitate timely intervention. EWS intend to prompt early actions, such as increased nursing attention or informing clinicians for more intensive care. Traditional EWS, such as the commonly used NEWS2 score in NHS hospitals, iss...

Product types

Collaborative R&D CR&D Bilateral Department for Science, Innovation & Technology EU-Funded Feasibility Studies Grant for R&D Knowledge Transfer Partnership Study